Search - tctmd.com

Displaying 161 - 180 of 297

Sort: Relevancy | Date

News Daily News

One Less Pill in Elderly Hypertensive Patients Safe in the Short Term

Shelley Wood

June 05, 2020

News Features

Cardiology After COVID-19: Physicians Predict Lasting Change

Yael L. Maxwell

May 20, 2020

News Daily News

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

Todd Neale

May 06, 2020

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

News Daily News

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Caitlin E. Cox

March 24, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Daily News

AHA: Advice on Lifestyle, Risk Factor Modification to Cut A-fib Events

Yael L. Maxwell

March 13, 2020

News Opinion Editor's Corner

COVID-19 and the Heart: Insights From the Front Lines

Shelley Wood

March 12, 2020

News Daily News

Meta-analysis Questions PCI vs CABG in Women With Multivessel Disease

Shelley Wood

February 27, 2020

News Daily News

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

Shelley Wood

February 14, 2020

News Daily News

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

Yael L. Maxwell

January 28, 2020

News Daily News

Obesity and Aortic Stenosis: Genetic Analysis Hints at Causal Link

Yael L. Maxwell

January 13, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News CV Team Pro

The Emory Healthcare Cath Lab Teams

L.A. McKeown

December 18, 2019

News Daily News

‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD

Yael L. Maxwell

December 12, 2019

News Opinion Editor's Corner

ISCHEMIA Questions? Some Answers From David Maron

Shelley Wood

December 09, 2019

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Todd Neale

November 17, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Daily News

Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most

Yael L. Maxwell

November 07, 2019

Advertisement

One Less Pill in Elderly Hypertensive Patients Safe in the Short Term

Cardiology After COVID-19: Physicians Predict Lasting Change

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Inclisiran Data in NEJM Prompt Talk of What Comes Next

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

AHA: Advice on Lifestyle, Risk Factor Modification to Cut A-fib Events

COVID-19 and the Heart: Insights From the Front Lines

Meta-analysis Questions PCI vs CABG in Women With Multivessel Disease

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

Obesity and Aortic Stenosis: Genetic Analysis Hints at Causal Link

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

The Emory Healthcare Cath Lab Teams

‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD

ISCHEMIA Questions? Some Answers From David Maron

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content